School of Medicine to serve as lead site for clinical trial on stuttering

Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.

By Iqbal Pittalwala | | Health

UC Riverside and Neuroscience Education Institute partner to deliver continuing medical education nationwide

Content developed by School of Medicine for physicians and other health care professionals includes grand rounds and a journal club delivered virtually

By Iqbal Pittalwala | | Health

Addiction Medicine Fellowship program receives initial accreditation

The first class of fellows begins training in the Coachella Valley’s Betty Ford Center and Eisenhower Medical Center on July 1

By Iqbal Pittalwala | | Health

UCR Health moves to telehealth in COVID-19 crisis

Telehealth visits can be conducted on a cell phone, tablet, or pad device, allowing even individuals without a computer or internet to be seen by a UCR Health physician

By Iqbal Pittalwala | | Health

Ecopipam reduces stuttering symptoms in proof-of-concept trial

UC Riverside-led open-label pilot study leads to a double-blind clinical trial to further test ecopipam’s efficacy and safety in adult patients who stutter

By Iqbal Pittalwala | | Health